Bio

When complex health care regulations threaten a company’s future, reputation, or strategic deal, attorney David Matyas negotiates favorable solutions for clients. He defends hospital systems, home care providers, physician practices, and other providers in government investigations, audits, and related claims of fraud, false claims, anti-kickback statute violations, and noncompliant behavior. In addition, David uses his regulatory depth to guide emerging health care companies and their private equity investors. In an industry filled with uncertainty and change, David reduces legal risks for clients, which range from startups to industry leaders. He distills decades of regulatory law into common-sense compliance programs and practical, strategic advice. Persuasive and diplomatic, David is most effective in contentious and sensitive matters, including negotiations with government authorities. His committed advocacy has helped eliminate or reduce clients’ exposure to program exclusion, criminal liability, corporate integrity agreements, and other penalties. David is equally skilled before corporate boards, executive teams, entrepreneurs, and founders. Clients are reassured by the options he offers for growth, governance, and risk reduction at every stage of the business cycle. Amid health care’s busy mergers and acquisitions (M&A) activity, David’s deal regulatory due diligence is keeping private equity clients competitive. He identifies potential risks and pitfalls in target companies and offers remedies to prevent good deals from being derailed. David places clients ahead of quick-moving developments through his career-long leadership of the American Health Law Association. David is a frequent speaker and author on the subjects of health care fraud, corporate compliance programs, the Stark Law, M&A in the health care industry, and other health-related topics. He is also Managing Shareholder of Epstein Becker Green’s Washington, DC, office.